1 results match your criteria: "Research Institute of Pulmonology. I.P. Pavlov First Saint Petersburg State Medical University[Affiliation]"
Efficacy of Arbidol in the prevention of virus-induced exacerbations of bronchial asthma and chronic obstructive pulmonary disease.
Ter Arkh
August 2018
Research Institute of Pulmonology. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of the Russia, Saint Petersburg, Russia.
Article Synopsis
- The study aimed to evaluate how effective and safe Arbidol is for preventing influenza and ARVI in patients with asthma and COPD.
- The research involved 100 patients, who took umifenovir for a specific duration during the 2016-2017 flu season, and their health records when not on the medication were used for comparison.
- Results showed that umifenovir reduced illness incidence and severity, with fewer complications and exacerbations in the treated group than the control group.